Highlights Bone Biologics Corporation

Equities

BBLG

US0980705018

Market Closed - Nasdaq Other stock markets 21:30:00 02/07/2024 BST			5-day change	1st Jan Change
1.22 ^USD	+1.67%		+0.83%	-73.01%

06-20	Bone Biologics Corporation Announces First Two Patients Treated in Pilot Clinical Study with Bone Biologics NB1 Bone Graft Device in Spine Fusion	CI
05-14	Bone Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bone Biologics Corporation Announces First Two Patients Treated in Pilot Clinical Study with Bone Biologics NB1 Bone Graft Device in Spine Fusion	06-20	CI
Bone Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Bone Biologics Corporation Reports Progress with NB1 Clinical Program	03-01	CI
Bone Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	02-21	CI
Bone Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Bone Biologics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Bone Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Bone Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23	CI
Bone Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
Bone Biologics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22	CI
Bone Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22	CI
Bone Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	15/03/22	CI
Bone Biologics to Receive Demineralized Bone Matrix Supply From MTF Biologics	07/03/22	MT
Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix	07/03/22	CI
Bone Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21	CI
Bone Biologics Corporation has completed an IPO in the amount of $7.929889 million.	13/10/21	CI
Bone Biologics Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021	16/08/21	CI
Bone Biologics Corporation has filed an IPO in the amount of $6.8 million.	28/06/21	CI
Bone Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	21/05/21	CI
Bone Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2019	30/03/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bone Biologics Corporation

Equities

BBLG

US0980705018

Highlights

Filters